Samy Elayi, MD
Clinical Cardiac Electrophysiology · Lexington, KYNPI 1760698609
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Abbott accounts for 69.9% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $1,532, more than ten times the $143 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in KY, where the typical reported total is $16,637.
Across 85 payments — averaging $65.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Biosense Webster, Inc.$476
- Atricure, Inc.$283
- Boston Scientific$200
- Elutia, Inc.$106
- Pfizer$97
- plus $499 from 15 others
Across 21 payments — averaging $3090.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Elutia, Inc.$52K
- Abbott$13K
What the payments were for
- Consulting fees$1,00018%
- Travel & lodging$2,51145%
- Food & beverage$2,01436%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 25 | $3,864 |
| Biosense Webster, Inc. | 8 | $476 |
| Atricure, Inc. | 6 | $283 |
| Boston Scientific | 7 | $200 |
| Elutia, Inc. | 6 | $106 |
| Pfizer | 6 | $97 |
| Medtronic(2 entities) | 3 | $92 |
| Sanofi-aventis U.S. LLC | 4 | $66 |
| Irhythm Technologies, Inc. | 3 | $58 |
| Amgen | 3 | $43 |
| Cardiva Medical, Inc. | 2 | $40 |
| Novartis | 2 | $39 |
| Merck | 2 | $38 |
| Biotronik Inc. | 1 | $20 |
| Philips North America LLC | 1 | $18 |
| Chiesi USA, Inc. | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $18 |
| Johnson & Johnson | 1 | $14 |
| Scpharmaceuticals Inc. | 1 | $14 |
| Novo Nordisk | 1 | $13 |
| Surmodics, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$2,135
- Accent Pacemaker$1,000
- EPI-SENSE GUIDED COAGULATION SYS$196
- Carto 3$140
- CartoUnivu$105
How this compares
$5,526 in reported general payments places this provider in the 15th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
See all clinical cardiac electrophysiology providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 390 | $413,045 |
| XareltoRivaroxaban | 121 | $143,253 |
| MultaqDronedarone Hcl | 64 | $87,975 |
| EntrestoSacubitril/Valsartan | 48 | $71,877 |
| CorlanorIvabradine Hcl | 43 | $36,507 |
| Dofetilide | 204 | $31,219 |
| Amiodarone Hcl | 264 | $6,191 |
| Flecainide Acetate | 130 | $4,995 |
| Propafenone Hcl ErPropafenone Hcl | 12 | $3,598 |
| Metoprolol Succinate | 278 | $3,237 |
| SotalolSotalol Hcl | 127 | $3,112 |
| Ivabradine Hcl | 12 | $2,901 |
| Potassium Chloride | 102 | $1,973 |
| Amlodipine Besylate | 200 | $1,020 |
| Digoxin | 45 | $951 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $97 | $413,045390 claims |
| Johnson & JohnsonXarelto | $14 | $143,253121 claims |
| Sanofi-aventis U.S. LLCMultaq | $66 | $87,97564 claims |
| NovartisEntresto | $39 | $71,87748 claims |
| AmgenCorlanor | $43 | $36,50743 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
Other clinical cardiac electrophysiology in Lexington
- Johan AasboLexington$451K
- Gery TomassoniLexington$196K
- John LeeLexington$139K
- Joseph SouzaLexington$110K
- David CharlesLexington$32K
- Samuel OmotoyeLexington$32K
- Yousef DarratLexington$29K
- Joel SimonLexington$23K
- Karam AyoubLexington$15K
- Ahmed NagyLexington$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.